Editor's Choice - Optimal Threshold for the Volume-Outcome Relationship After Open AAA Repair in the Endovascular Era: Analysis of the International Consortium of Vascular Registries.


Journal

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
ISSN: 1532-2165
Titre abrégé: Eur J Vasc Endovasc Surg
Pays: England
ID NLM: 9512728

Informations de publication

Date de publication:
05 2021
Historique:
received: 28 07 2020
revised: 08 02 2021
accepted: 11 02 2021
pubmed: 17 3 2021
medline: 23 6 2021
entrez: 16 3 2021
Statut: ppublish

Résumé

As open abdominal aortic aneurysm (AAA) repair (OAR) rates decline in the endovascular era, the endorsement of minimum volume thresholds for OAR is increasingly controversial, as this may affect credentialing and training. The purpose of this analysis was to identify an optimal centre volume threshold that is associated with the most significant mortality reduction after OAR, and to determine how this reflects contemporary practice. This was an observational study of OARs performed in 11 countries (2010 - 2016) within the International Consortium of Vascular Registry database (n = 178 302). The primary endpoint was post-operative in hospital mortality. Two different methodologies (area under the receiving operating curve optimisation and Markov chain Monte Carlo procedure) were used to determine the optimal centre volume threshold associated with the most significant mortality improvement. In total, 154 912 (86.9%) intact and 23 390 (13.1%) ruptured AAAs were analysed. The majority (63.1%; n = 112 557) underwent endovascular repair (EVAR) (OAR 36.9%; n = 65 745). A significant inverse relationship between increasing centre volume and lower peri-operative mortality after intact and ruptured OAR was evident (p < .001) but not with EVAR. An annual centre volume of between 13 and 16 procedures per year was associated with the most significant mortality reduction after intact OAR (adjusted predicted mortality < 13 procedures/year 4.6% [95% confidence interval 4.0% - 5.2%] vs. ≥ 13 procedures/year 3.1% [95% CI 2.8% - 3.5%]). With the increasing adoption of EVAR, the mean number of OARs per centre (intact + ruptured) decreased significantly (2010 - 2013 = 35.7; 2014 - 2016 = 29.8; p < .001). Only 23% of centres (n = 240/1 065) met the ≥ 13 procedures/year volume threshold, with significant variation between nations (Germany 11%; Denmark 100%). An annual centre volume of 13 - 16 OARs per year is the optimal threshold associated with the greatest mortality risk reduction after treatment of intact AAA. However, in the current endovascular era, achieving this threshold requires significant re-organisation of OAR practice delivery in many countries, and would affect provision of non-elective aortic services. Low volume centres continuing to offer OAR should aim to achieve mortality results equivalent to the high volume institution benchmark, using validated data from quality registries to track outcomes.

Identifiants

pubmed: 33722485
pii: S1078-5884(21)00168-4
doi: 10.1016/j.ejvs.2021.02.018
pii:
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

747-755

Subventions

Organisme : FDA HHS
ID : U01 FD005478
Pays : United States
Organisme : FDA HHS
ID : U01 FD006936
Pays : United States

Informations de copyright

Copyright © 2021 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.

Auteurs

Salvatore T Scali (ST)

University of Florida College of Medicine, Division of Vascular Surgery & Endovascular Therapy, Gainesville, FL, USA. Electronic address: salvatore.scali@surgery.ufl.edu.

Adam Beck (A)

Division of Vascular Surgery and Endovascular Therapy, University of Alabama at Birmingham, Birmingham, AL, USA.

Art Sedrakyan (A)

Population Health Sciences, Weill Cornell Medical College, New York, NY, USA.

Jialin Mao (J)

Population Health Sciences, Weill Cornell Medical College, New York, NY, USA.

Christian-Alexander Behrendt (CA)

Department of Vascular Medicine, Working Group GermanVasc, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Jonathan R Boyle (JR)

Cambridge Vascular Unit, Addenbrooke's Hospital, Cambridge University Hospitals NHS Trust, Cambridge, UK.

Maarit Venermo (M)

Department of Vascular Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Rumi Faizer (R)

Division of Vascular Surgery, University of Minnesota, Minneapolis, MN, USA.

Marc Schermerhorn (M)

Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Centre, Boston, MA, USA.

Barry Beiles (B)

Australasian Vascular Audit, Australasian Society for Vascular Surgery, Melbourne, Australia.

Zoltan Szeberin (Z)

Department of Vascular Surgery, Semmelweis University, Budapest, Hungary.

Nikolaj Eldrup (N)

Department of Vascular Surgery, Rigshospitalet, Copenhagen University, Copenhagen, Denmark.

Ian Thomson (I)

Department of Surgery, University of Otago, Dunedin, New Zealand.

Kevin Cassar (K)

Department of Surgery, Faculty of Medicine and Surgery, University of Malta, Malta.

Martin Altreuther (M)

Department of Vascular Surgery, St. Olavs Hospital, Trondheim, Norway.

Sebastian Debus (S)

Department of Vascular Medicine, Working Group GermanVasc, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Amundeep Johal (A)

The Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, UK.

Martin Bjorck (M)

Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

Jack L Cronenwett (JL)

Section of Vascular Surgery, Dartmouth-Hitchcock Medical Centre, Lebanon, NH, USA.

Kevin Mani (K)

Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH